Allosterically controllable maxizymes cleave mRNA with high efficiency and specificity

Bratty, 1993, The hammerhead RNA domain, a model ribozyme, Biochim. Biophys. Acta, 1216, 345, 10.1016/0167-4781(93)90001-T Dahm, 1993, Role of divalent metal ions in the hammerhead RNA cleavage reaction, Biochemistry, 32, 13040, 10.1021/bi00211a013 Piccirilli, 1993, Metal ion catalysis in the Tetrahymena ribozyme reaction, Nature, 361, 85, 10.1038/361085a0 Pyle, 1993, Ribozymes: a distinct class of metalloenzymes, Science, 261, 709, 10.1126/science.7688142 Steitz, 1993, A general two-metal-ion mechanism for catalytic RNA, Proc. Natl. Acad. Sci. U. S. A., 90, 6498, 10.1073/pnas.90.14.6498 Uchimaru, 1993, Theoretical analyses on the role of Mg2+ ions in ribozyme reactions, FASEB J., 7, 137, 10.1096/fasebj.7.1.8422960 Yarus, 1993, How many catalytic RNAs? Ions and the Cheshire cat conjecture, FASEB J., 7, 31, 10.1096/fasebj.7.1.8422972 Uebayasi, 1994, Theoretical and experimental considerations on the hammerhead ribozyme reactions: divalent magnesium-ion mediated cleavage of phosphorus-oxygen bonds, J. Org. Chem., 59, 7414, 10.1021/jo00103a038 Sawata, 1995, Kinetic evidence based on solvent isotope effects for the nonexistence of a proton-transfer process in reactions catalysed by a hammerhead ribozyme: implication to the double-metal-ion mechanism of catalysis, J. Am. Chem. Soc., 117, 2357, 10.1021/ja00113a028 Zhou, 1996, Evidence for the rate-limiting departure of the 59-oxygen in nonenzymatic and hammerhead ribozyme-catalysed reactions, J. Am. Chem. Soc., 118, 5862, 10.1021/ja9606790 Birikh, 1997, The hammerhead ribozyme-structure, function and application, Eur. J. Biochem., 245, 1, 10.1111/j.1432-1033.1997.t01-3-00001.x Weinstein, 1997, A second catalytic metal ion in group I ribozyme, Nature, 388, 805, 10.1038/42076 Zhou, 1997, Explanation by the double-metal-ion mechanism of catalysis for the differential metal ion effects on the cleavage rates of 59-oxy and 59-thio substrates by a hammerhead ribozyme, Proc. Natl. Acad. Sci. U. S. A., 94, 14343, 10.1073/pnas.94.26.14343 Lott, 1998, A two-metal ion mechanism operates in the hammerhead ribozyme-mediated cleavage of an RNA substrate, Proc. Natl. Acad. Sci. U. S. A., 95, 542, 10.1073/pnas.95.2.542 Murray, 1998, The hammerhead, hairpin and VS ribozymes are catalytically proficient in monovalent cations alone, Chem. Biol., 5, 587, 10.1016/S1074-5521(98)90116-8 Zhou, 1998, The hydrolysis of RNA: from theoretical calculations to the hammerhead ribozyme-mediated cleavage of RNA, Chem. Rev., 98, 991, 10.1021/cr9604292 Yoshinari, 2000, A further investigation and reappraisal of the thio effect in the cleavage reaction catalysed by a hammerhead ribozyme, Nucleic Acids Res., 28, 1730, 10.1093/nar/28.8.1730 Hendry, 1992, A ribozyme with DNA in the hybridising arms displays enhanced cleavage ability, Nucleic Acids Res., 20, 5737, 10.1093/nar/20.21.5737 Taylor, 1992, Chimeric DNA–RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo, Nucleic Acids Res., 20, 4559, 10.1093/nar/20.17.4559 Sawata, 1993, Enhancement of the cleavage rates of DNA-armed hammerhead ribozymes by various divalent metal ions, Nucleic Acids Res., 21, 5656, 10.1093/nar/21.24.5656 Shimayama, 1993, Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages, Nucleic Acids Res., 21, 2605, 10.1093/nar/21.11.2605 Warashina, 1997, Entropically driven enhancement of cleavage activity of a DNA-armed hammerhead ribozyme: mechanism of action of hammerhead ribozymes, J. Org. Chem., 62, 9138, 10.1021/jo9712411 McCall, 1992, Minimal sequence requirements for ribozyme activity, Proc. Natl. Acad. Sci. U. S. A., 89, 5710, 10.1073/pnas.89.13.5710 Tuschl, 1993, Hammerhead ribozymes: importance of stem-loop II activity, Proc. Natl. Acad. Sci. U. S. A., 90, 6991, 10.1073/pnas.90.15.6991 Fu, 1994, Hammerhead ribozymes containing non-nucleoside linkers are active RNA catalysts, J. Am. Chem. Soc., 116, 4591, 10.1021/ja00090a007 Long, 1994, Kinetic characterization of intramolecular and intermolecular hammerhead RNAs with stem II deletions, Proc. Natl. Acad. Sci. U. S. A., 91, 6977, 10.1073/pnas.91.15.6977 Amontov, 1996, Hammerhead minizymes with high cleavage activity: a dimeric structure as the active conformation of minizymes, J. Am. Chem. Soc., 118, 1624, 10.1021/ja9517734 Kuwabara, 1998, Formation of a catalytically active dimer by tRNAVal-driven short ribozymes, Nat. Biotech., 16, 961, 10.1038/nbt1098-961 Kuwabara, 1996, Characterization of several kinds of dimer minizyme: simultaneous cleavage at two sites in HIV-1 tat mRNA by dimer minizymes, Nucleic Acids Res., 24, 2302, 10.1093/nar/24.12.2302 Kuwabara, 1999, Novel tRNAVal-heterodimeric maxizymes with high potential as gene-inactivating agents: Simultaneous cleavage at two sites in HIV-1 tat mRNA in cultured cells, Proc. Natl. Acad. Sci. U. S. A., 96, 1886, 10.1073/pnas.96.5.1886 Nakayama, 1999, CTAB-mediated enrichment for active forms of novel dimeric maxizymes, FEBS Lett., 448, 67, 10.1016/S0014-5793(99)00325-7 Koizumi, 1988, Cleavage of specific sites of RNA by designed ribozymes, FEBS Lett., 228, 228, 10.1016/0014-5793(88)80004-8 Sheldon, 1989, Mutagenesis analysis of a self-cleaving RNA, Nucleic Acids Res., 17, 5679, 10.1093/nar/17.14.5679 Ruffner, 1990, Sequence requirements of the hammerhead RNA self-cleavage reaction, Biochemistry, 29, 10695, 10.1021/bi00499a018 Perriman, 1992, Extended target-site specificity for a hammerhead ribozyme, Gene, 113, 157, 10.1016/0378-1119(92)90391-2 Shimayama, 1995, Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes, Biochemistry, 34, 3649, 10.1021/bi00011a020 Zoumadakis, 1995, Comparative analysis of cleavage rates after systematic permutation of the NUX consensus target motif for hammerhead ribozymes, Nucleic Acids Res., 23, 1192, 10.1093/nar/23.7.1192 Kore, 1998, Sequence specificity of the hammerhead ribozyme revisited; the NHH rule, Nucleic Acids Res., 26, 4116, 10.1093/nar/26.18.4116 Rowley, 1973, A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining, Nature, 243, 290, 10.1038/243290a0 Bartram, 1983, Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukemia, Nature, 306, 277, 10.1038/306277a0 Heisterkamp, 1983, Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukemia, Nature, 306, 239, 10.1038/306239a0 Groffen, 1984, Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22, Cell, 6, 93, 10.1016/0092-8674(84)90077-1 Shtivelman, 1986, Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line, Cell, 47, 277, 10.1016/0092-8674(86)90450-2 Konopka, 1984, An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity, Cell, 37, 1035, 10.1016/0092-8674(84)90438-0 Snyder, 1990, Treatment of chronic myelogenous leukemia with bone marrow transplantation, Hematol. Oncol. Clin. North Am., 4, 535, 10.1016/S0889-8588(18)30477-5 McGlave, 1993, Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program, Blood, 81, 543, 10.1182/blood.V81.2.543.543 Deisseroth, 1994, Genetic marking shows that Ph1 cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML, Blood, 83, 3068, 10.1182/blood.V83.10.3068.3068 Daley, 1990, Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome, Science, 247, 824, 10.1126/science.2406902 Gishizky, 1992, Initiation of deregulated growth of multipotent progenitor cells by bcr–abl in vitro, Science, 256, 836, 10.1126/science.1375394 Kuwabara, 1998, A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo, Mol. Cell, 2, 617, 10.1016/S1097-2765(00)80160-4 Kuwabara, 1997, Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA, Nucleic Acids Res., 25, 3074, 10.1093/nar/25.15.3074 Sullenger, 1993, Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA, Science, 262, 1566, 10.1126/science.8248806 Bertrand, 1997, The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization, RNA, 3, 75 Good, 1997, Expression of small, therapeutic RNAs in human cell nuclei, Gene Ther., 4, 45, 10.1038/sj.gt.3300354 Du, 1998, Efficient ex vivo inhibition of perforin and Fas ligand expression by chimeric tRNA-hammerhead ribozymes, Hum. Gene Ther., 9, 1551, 10.1089/hum.1998.9.11-1551 Koseki, 1999, Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III, J. Virol., 73, 1868, 10.1128/JVI.73.3.1868-1877.1999 Rossi, 1990, RNA enzymes (ribozymes) as antiviral therapeutic agents, Trends Biotechnol., 8, 179, 10.1016/0167-7799(90)90169-X Sarver, 1990, Ribozymes as potential anti-HIV-1 therapeutic agents, Science, 247, 1222, 10.1126/science.2107573 Erickson, R.P. and Izant, J. (1992) Gene Regulation: Biology of Antisense RNA and DNA, Raven Press Murray, J.A.H. (1992) Antisense RNA and DNA, Wiley-Liss Inc., New York Rossi, 1995, Controlled, targeted, intracellular expression of ribozymes: progress and problems, Trends Biotechnol., 13, 301, 10.1016/S0167-7799(00)88969-6 Eckstein, F. and Lilley, D.M.J. (1996) Nucleic acids and molecular biology: Catalytic RNA, 10, Springer-Verlag. Turner, P.C. (1997) Methods in Molecular Biology: Ribozyme Protocols, 74, Humana Press, Totowa, N.J. Tanabe, 2000, Oncogene inactivation in a mouse model: tissue invasion by leukaemic cells is stalled by loading them with a designer ribozyme, Nature, 406, 473, 10.1038/35020190 Tanabe, 2000, Maxizymes, novel allosterically controllable ribozymes can be designed to cleave various substrates, Biomacromol., 1, 108, 10.1021/bm990009x Soukup, 1999, Nucleic acids molecular switches, Trends Biotechnol., 17, 469, 10.1016/S0167-7799(99)01383-9 Marshall, 1999, Training ribozymes to switch, Nat. Struc. Biol., 6, 992, 10.1038/14872 Hamada, 1999, Specificity of novel allosterically trans- and cis-activated connected maxizymes that are designed to suppress BCR–ABL expression, FEBS Lett., 461, 77, 10.1016/S0014-5793(99)01367-8 Zhou, 2000, Chemical and enzymatic probing of effector-mediated changes in the conformation of a maxizyme, J. Inorg. Biochem., 78, 261, 10.1016/S0162-0134(00)00005-2